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The authors should be commended for helping improve the issue of implant rippling. This article addresses two different issues that revolve around rippling. One is the accurate description and classification of rippling and its presentation in the breast after implant surgery. The other is treatment plans for the rippling and emerging options. This classification can be used to plan for treatment based on the severity. Similar to capsular contractures grading scale, we can share our scientific findings in a more helpful manner.
Part of plastic surgery that helps us advance as a field is critically analyzing our techniques and ways to improve them. The first step toward improvement is being able to describe the problem. The patient questionnaire database, BREAST-Q, asks about the expectations of the patient's breast augmentation or reconstruction based on the visibility and palpability of the implant rippling (up to 1 year out). This database is limited due to its follow-up beyond one year and the specificity of its questions. BREAST-Q does not distinguish the differences between positional rippling and rippling in the upright position [1] [2] [3] . With the grades of rippling presented in this article, the rippling associated with breast implants can be more accurately described. With most grading scales, the purpose is to help communicate between physicians as well as help with management. Therefore, grading rippling can help by more accurately treating and/or preventing rippling. Part of the difficulty with helping develop guidelines for treatment lies in the fact that the rippling is likely underreported. Rippling may not be present for several years after breast augmentation, and most studies stop after a few years of follow-up or they may not analyze rippling critically all together. Also making it difficult is the ambiguous wording to describe this condition. Many articles mention rippling and/or palpability as a result of implant breast surgery; however, there is a no attempt to categorize the rippling for therapeutic management [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Rippling is often poorly described or quantified as well as interchangeable with palpability in some papers [8, 9] . The authors did a good job in grading 1 with palpable only, grade 2 with positional rippling and grade 3 with visible rippling with the patient upright. The grade 1a and 1b seems to describe the most common areas; however, if this is the case, other areas of rippling should be included in the scale (superior, inferior pole). This seems to apply to the breast reconstruction and prepectoral breast augmentation as superior pole rippling is common with thinner chest walls [10, 11] .
Although the article does a nice job in painting the general ideas of what can cause rippling and possible ways to manage it, the power of this article lies in the language we can now use when describing rippling. The classification can now lead to improved communication on complications and ways to correct or prevent rippling. For example, for grade 1 rippling, we may suggest fat transfer alone could be acceptable. For grade 2, it may be recommended to increase implant size with fat transfer, ADM or pocket tightening. For grade 3, changing implant size, adding ADM with fat and tightening the pocket may be recommended. With a grading scale, it may be possible to specifically address how to help predict which patients may develop each of the various grades of rippling. Our next step as a community is to try to predict the patients who are at risk and perform preventive measures, such as fat transfer and/or ADM at the time of the implant placement. As this paper mentions, some rippling is from the impression of the implant surface to the overlying tissues, enlargement of the pocket which creates laxity and pulling of the overlying tissues, implant shape-over-or underfilled causing more folds in the shell. Corrections and prevention include increasing tissue coverage with fat, autologous tissue and/or ADM; reinforcing the pocket with ADM to create a snug fit around the implant; changing the implant texture to smooth to allow for less noticeable rippling; and/or increasing the fill of the implants. As we are learning to treat and hopefully prevent rippling, this helps us better guide our patients in choosing the best initial surgery. Longer-term studies, noting specifically when the rippling presents, may help educate the patients and temper their expectations on future rippling. This would be similar to informing patients with very stretch skin that another breast lift will be likely in the future. If they could not accept rippling, then maybe breast augmentation would not be ideal for them. This article is a great step forward in breast rippling management.
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